Belgium's Gimv sells remaining Ablynx stake
BRUSSELS (Reuters) - Belgian investment fund Gimv (GIMV.BR) said it sold its remaining stake in biotech firm Ablynx (ABLX.BR) after partnering the company for 12 years.
Gimv said the exit has a positive impact of 3.8 million euros on its last published equity value, and it would use the proceeds to make other investments in the biotech sector.
(Reporting by Robert-Jan Bartunek)
NEW YORK - U.S. stocks fell on Thursday, with the Dow and S&P 500 dropping for a fifth straight session after a round of mixed economic data left traders guessing as to when the Federal Reserve would begin to slow its stimulus program. | Video
BEIJING/HONG KONG - China reiterated its opposition on Thursday to a European Union plan to limit airline carbon dioxide emissions and called for talks to resolve the issue a day after its major airlines refused to pay any carbon costs under the new law.